Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA7 | P43166 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.43 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.43 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591833 | 1.00 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL28707518 | 0.97 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL28865561 | 0.97 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3410859 | 0.97 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL2154758 | 0.97 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL5529210 | 0.89 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14652933 | 0.87 | CA1 (0.59) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14604131 | 0.87 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12773676 | 0.87 | NFE2L2 (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4444463 | 0.86 | CA1 (0.50) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606742-B2 | Method for preparing quantum dot, quantum dot, and display device | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2026-04-21 | — | — | US | claimed |
| EP-4186960-B1 | PREPARATION METHOD OF ZNSE QUANTUM DOT, ZNSE QUANTUM DOT, ZNSE STRUCTURE, AND DISPLAY DEVICE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2026-03-25 | — | — | EP | claimed |
| CN-117062895-B | Quantum dot preparation method, quantum dot and display device | 京东方科技集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12221575-B2 | Method for preparing ZnSe quantum dot, ZnSe quantum dot, ZnSe structure and display device | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2025-02-11 | — | — | US | claimed |
| CN-119039346-A | Ligand of polyketone resin polymerization catalyst, preparation method and application thereof | 上海优铖工逸技术有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-114981385-B | Preparation method of ZnSe quantum dot, znSe structure and display device | 京东方科技集团股份有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-117062895-A | Quantum dot preparation method, quantum dot and display device | 京东方科技集团股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-116535441-B | Catalyst ligand and preparation method and application thereof | 上海优铖工逸技术有限公司 | 2023-11-03 | — | — | CN | claimed |
| WO-2023168684-A1 | METHOD FOR PREPARING QUANTUM DOT, AND QUANTUM DOT AND DISPLAY DEVICE | 京东方科技集团股份有限公司 | 2023-09-14 | — | — | WO | claimed |
| CN-116535441-A | Catalyst ligand and preparation method and application thereof | 上海优铖工逸技术有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-114106048-A | Synthetic method of polyketone ligand | 黄河三角洲京博化工研究院有限公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3023448-B1 | POLYKETONE POLYMERIZATION CATALYST | HYOSUNG CHEMICAL CORP (KR) | 2018-11-14 | — | — | EP | claimed |
| US-20160333036-A1 | POLYKETONE POLYMERIZATION CATALYST | Hyosung Chemical Corporation (KR) | 2016-11-17 | — | — | US | claimed |
| EP-3023448-A1 | POLYKETONE POLYMERIZATION CATALYST | Hyosung Corporation (KR) | 2016-05-25 | — | — | EP | claimed |
| EP-1100832-A1 | A POLYMERIZATION PROCESS | Basell Technology Company B.V. (NL) | 2001-05-23 | — | — | EP | claimed |
| WO-2000006615-A1 | A POLYMERIZATION PROCESS | BASELL TECHNOLOGY COMPANY B.V. (NL) | 2000-02-10 | — | — | WO | claimed |
| US-5648549-A | Process for the preparation of secondary arylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-07-15 | — | — | US | claimed |
| EP-0754694-A1 | Process for the preparation of secondary arylphosphanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-01-22 | — | — | EP | claimed |
| US-5118854-A | Reacting alkali metal and tri(2-alkoxyphenyl)-phosphine in liquid ammonia | SHELL OIL COMPANY (US) | 1992-06-02 | — | — | US | claimed |
| EP-0286196-B1 | PREPARATION OF SUBSTITUTED DIARYL PHOSPHIDES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-03-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160333036-A1 | POLYKETONE POLYMERIZATION CATALYST | PNKP, PANK1, DMPK | CA1 3932/4885CA2 3520/4885CA7 1115/4885 |
| US-12606742-B2 | Method for preparing quantum dot, quantum dot, and display device | TPO, SALL4, SELENOI | CA1 746/4885CA2 1221/4885CA7 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.